(Q40946924)

25 September 2017

1 reference

title

Sensitivity analysis in economic evaluation: a review of published studies (English)

1 reference

25 September 2017

Briggs A

1

1 reference

PubMed ID

8563834

25 September 2017

Sculpher M

series ordinal

2

1 reference

PubMed ID

8563834

25 September 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

25 September 2017

1 reference

25 September 2017

4

1 reference

25 September 2017

5

1 reference

25 September 2017

355-371

1 reference

Clinical economics. A guide to the economic analysis of clinical practices

25 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Cost-utility in practice: a policy maker's guide to the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Costs, effects and C/E-ratios alongside a clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

The economic impact of HA-1A (Centoxin) against endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Screening infants for hearing loss--an economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Cost-effectiveness comparison of single and multiple-dose antibiotic treatment of lower uncomplicated urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Cost effectiveness of extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy for medium-sized kidney stones. A randomised clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

The cost-effectiveness of replacing high-osmolality with low-osmolality contrast media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

HRT: an analysis of benefits, risks and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Cost-effectiveness of single dose cefotaxime plus metronidazole compared with three doses each of cefuroxime plus metronidazole for the prevention of wound infection after colorectal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Hearing impairments in middle age: the acceptability, benefit and cost of detection (ABCD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Is repeated coronary surgery for recurrent angina cost effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Cost effectiveness of cervical cancer screening for the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Cost-effectiveness of the screening and treatment of diabetic retinopathy. What are the costs of underutilization?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Percutaneous needle biopsy of musculoskeletal lesions. 2. Cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Optimal management strategies for HIV-infected patients who present with cough or dyspnea: a cost-effective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Radiation therapy: a long term cost benefit analysis in a North American region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

A comparison of the cost-effectiveness of day treatment and residential treatment for children with severe behaviour problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

A cost utility analysis of mammography screening in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Analysis of cost-effectiveness of different strategies for hepatocellular carcinoma screening in hepatitis B virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Treatment of natal cleft sinus: a prospective clinical and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Cost-effectiveness of thrombolysis--a randomized study of intravenous rt-PA in suspected myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

A cost-effectiveness study of the management of intractable urinary incontinence by urinary catheterisation or incontinence pads

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Economic evaluation of oral ofloxacin versus standard parenteral therapy in the treatment of pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

The economic evaluation of malaria control technologies: The case of Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Randomised controlled trial of cost-effectiveness of lithotripsy and open cholecystectomy as treatments for gallbladder stones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Cost effectiveness of the implantable cardioverter defibrillator: a preliminary analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Potential cost savings of oral versus intravenous etoposide in the treatment of small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Cost-benefit analysis of an educational program for general practitioners by the Swedish Committee for the Prevention and Treatment of Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Short-chain fatty acid enemas: a cost-effective alternative in the treatment of nonspecific proctosigmoiditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Safety and Cost Effectiveness of High-Osmolality as Compared with Low-Osmolality Contrast Material in Patients Undergoing Cardiac Angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Filtering strategies in mass population screening for colorectal cancer: an economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

Economic assessments of medical practices and technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Estimating costs in the economic evaluation of medical technologies

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Economic analysis in randomized control trials

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Standardizing methodologies for economic evaluation in health care. Practice, problems, and potential

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Zidovudine for chemoprophylaxis after occupational exposure to HIV-infected blood: an economic evaluation

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Cost-effectiveness of a back school intervention for municipal employees

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Sensitivity analysis in the cost-effectiveness of breast cancer screening

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Cost-utility analysis of early thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Leuprolide acetate-prepared in vitro fertilization-gamete intrafallopian transfer cycles: efficacy versus controls and cost analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

A method to compare cost-effectiveness of dental treatments: adhesive bridges compared to conventional bridges

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

A cost-effective peripheral venous port system placed at the bedside

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

A comparison of the safety, timing and cost-effectiveness of administering antibiotics by intravenous bolus (push) versus intravenous piggyback (slow infusion) in surgical prophylaxis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Trans-radial primary percutaneous coronary intervention in dextrocardia using double inversion technique

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Community pharmacists as immunization advocates. Cost-effectiveness of a cue to influenza vaccination.

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

A cost-effectiveness analysis of three staffing models for the delivery of low-risk prenatal care

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Cost-effectiveness of simvastatin versus cholestyramine: results for Sweden

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Cost-effectiveness of misoprostol in Sweden

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Cost-effectiveness of alternative methods for diabetic retinopathy screening

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Cost-effectiveness of the implantable cardioverter-defibrillator: Effect of improved battery life and comparison with amiodarone therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

A comparison of the costs and benefits of recombinant human erythropoietin (epoetin) in the treatment of chronic renal failure in 5 European countries

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Cost-effectiveness analysis of the use of chlorhexidine detergent in preoperative whole-body disinfection in wound infection prophylaxis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Prevention of Lyme disease after tick bites. A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Cost-effectiveness decision analysis of obtaining periapical radiographs of traumatized maxillary incisors

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Cost-benefit analysis of hip fracture treatment

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Cost-effectiveness analysis of treatment with liposomal amphotericin B versus conventional amphotericin B in organ or bone marrow transplant recipients with systemic mycoses

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Effectiveness and cost efficiency of interventions in health promotion

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Cost-effectiveness of prophylactic AZT following needlestick injury in health care workers

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

The economics of an intensive education programme for asthmatic patients: a prospective controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

The antiemetic efficacy and the cost-benefit ratio of ondansetron calculated with a new approach to health technology assessment (real cost-benefit index)

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Cost-effectiveness analysis of hepatitis A prevention in travellers

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

An economic evaluation of home-care assistance for AIDS patients: a pilot study in a town in northern Italy

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

An economic evaluation of daycare in the management of hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Cost/benefit analysis of cardiopulmonary resuscitation: a comprehensive study--Part II

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Cost-effective management of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEC.4730040502

7 January 2021

Identifiers

DOI

10.1002/HEC.4730040502

1 reference

25 September 2017

1 reference

PubMed ID

8563834